Literature DB >> 9817717

Heparin improves gas exchange during experimental acute lung injury in newborn piglets.

K Abubakar1, B Schmidt, S Monkman, C Webber, D deSA, R Roberts.   

Abstract

Although intrapulmonary fibrin deposition is a pathognomonic feature of acute lung injury, it remains uncertain whether thrombin inhibitors affect clinically important outcomes. We hypothesized that both heparin and antithrombin (AT) concentrate improve gas exchange during experimental respiratory distress syndrome. We also tested whether combination therapy is more beneficial than monotherapy. Forty-eight newborn piglets were randomized within 12 litters to one of four groups in a factorial design: (1) AT; (2) heparin; (3) AT plus heparin; (4) untreated control animals. After lung lavage and 4 h of barovolutrauma, mechanical ventilation was continued for 24 h during which ventilator pressures and inspired oxygen were adjusted to maintain normal blood gases. The arterial/ alveolar oxygen tension ratio (a/A ratio) and the ventilator efficiency index (VEI) at 18 and 24 h were compared by repeated measures analysis of variance (ANOVA). In contrast to our hypothesis, only heparin improved gas exchange, and we found little evidence of an interaction with AT. The a/A ratio was 0.48 +/- 0.27 (mean +/- SD) in the presence of heparin versus 0.33 +/- 0.26 in its absence; p = 0.01. Corresponding VEI was 0.30 +/- 0.12 versus 0.25 +/- 0.14; p = 0.04. Hyaline membrane formation was also decreased in heparin-treated animals (p = 0.02).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817717     DOI: 10.1164/ajrccm.158.5.9803041

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

Review 1.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

2.  Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.

Authors:  D C Howell; N R Goldsack; R P Marshall; R J McAnulty; R Starke; G Purdy; G J Laurent; R C Chambers
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

3.  Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Authors:  Malgorzata Wygrecka; Philipp Markart; Ludger Fink; Andreas Guenther; Klaus T Preissner
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

4.  Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury.

Authors:  Gilman B Allen; Mary E Cloutier; Yuna C Larrabee; Konstantin Tetenev; Stephen T Smiley; Jason H T Bates
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-05       Impact factor: 5.464

Review 5.  Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome.

Authors:  Robert MacLaren; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705

6.  Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.

Authors:  Jorrit J Hofstra; Alexander P J Vlaar; David J Prins; Gavin Koh; Marcel Levi; Marcus J Schultz; Jan M Binnekade; Nicole P Juffermans
Journal:  BMC Pulm Med       Date:  2012-08-15       Impact factor: 3.317

7.  Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B.

Authors:  Li-Fu Li; Cheng-Ta Yang; Chung-Chi Huang; Yung-Yang Liu; Kuo-Chin Kao; Horng-Chyuan Lin
Journal:  Respir Res       Date:  2011-07-05

8.  Nebulized heparin is associated with fewer days of mechanical ventilation in critically ill patients: a randomized controlled trial.

Authors:  Barry Dixon; Marcus J Schultz; Roger Smith; James B Fink; John D Santamaria; Duncan J Campbell
Journal:  Crit Care       Date:  2010-10-11       Impact factor: 9.097

9.  Oral heparin: status review.

Authors:  Ehud Arbit; Michael Goldberg; Isabel Gomez-Orellana; Shingai Majuru
Journal:  Thromb J       Date:  2006-05-10

10.  Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.

Authors:  Li-Fu Li; Chung-Chi Huang; Horng-Chyuan Lin; Ying-Huang Tsai; Deborah A Quinn; Shuen-Kuei Liao
Journal:  Crit Care       Date:  2009-07-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.